Medicus Sciences Acquisition

General Information
We are a newly organized blank check company incorporated in November 2020 as a Cayman Islands exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.
While we may pursue an initial business combination opportunity in any industry or geographical location, we intend to capitalize on our management team’s background and experience to identify promising opportunities in the medical technology sector.
Employees: 0
Founded: 2020
Contact Information
Address 152 West 57th Street, Floor 20 New York, New York 10019, NY
Phone Number (212)259-8400
Web Address
View Prospectus: Medicus Sciences Acquisition
Financial Information
Market Cap $101mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol MSACU
Shares (millions): 8.0
Price range $10.00 - $10.00
Est. $ Volume $80.0 mil
Manager / Joint Managers Maxim Group
CO-Managers -
Expected To Trade:
Status: TBA
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change